Financials
Financial year 2025
BioEngLink from Gent, company number BE0750509487, closed financial year 2025 with a result of € 17,434 after tax. For that financial year BioEngLink recorded a gross margin of € 23,015 and equity of € 3,000. Compared with financial year 2024, the result moved from € 18,991 to € 17,434. The company is profitable. The buffer shrank hard: equity is 76 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 2, 2026.
€ 3,000
▼ 76% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 17,434
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 31,128
▼ 21% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 27,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 379
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,735
▼ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 15,570
▼ 33% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 15,027 | € 24,672 | € 24,665 | € 23,015 | ▼ 7% |
| Profit after taxes | € 11,514 | € 18,891 | € 18,991 | € 17,434 | ▼ 8% |
| Equity | € 24,683 | € 43,574 | € 12,566 | € 3,000 | ▼ 76% |
| Total debts | € 14,730 | € 12,353 | € 69,010 | € 41,756 | ▼ 39% |
| Cash | € 34,218 | € 36,115 | € 39,539 | € 31,128 | ▼ 21% |
| Retained profit | € 21,683 | € 40,574 | € 9,566 | € 0 | ▼ 100% |
| Dividend | € 0 | € 0 | € 50,000 | € 27,000 | ▼ 46% |
| Balance sheet total | € 39,413 | € 55,928 | € 81,576 | € 44,756 | ▼ 45% |
Key figures of BioEngLink, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to BioEngLink?
What happened at BioEngLink in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 17,434 (▼ 8% vs 2024). filed late Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
- Forward Malcolm became a director. NBB
In short
From € 11,514 profit in 2022 to € 17,434 profit in 2025.
Paid € 18,326 in corporate taxes since 2022.
Best year ever: 2024, with € 18,991 profit.
Paid out € 77,000 in dividends to the owners in total.
Management
Behind BioEngLink is Forward Malcolm.
Directors
According to the 2025 annual accounts
Forward Malcolm
Director
since 2020
Establishments
Establishment units
Physical locations of this company
De Pintelaan 24
9000 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0750.509.487
- VAT number
- BE 0750.509.487
- Registered office
- De Pintelaan 24, 9000 Gent
- Names & denominations
- BioEngLink
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 July 2020
- Peppol
- Active · Active since 20 Sept 2025
- Activities · NACE
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Installatie van industriële machines, toestellen en werktuigen
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Activiteiten van medische laboratoria
Computerconsultancy-activiteiten
+2